Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/2411
The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin
Ehud Chorin.
Matthew Dai.
Eric Shulman.
Lailt Wadhwani.
Roi Bar Cohen.
Chirag Barbhaiya.
Anthony Aizer.
Douglas Holmes.
Scott Bernstein.
Michael Soinelli.
David S Park.
Larry Chinitz.
Lior Jankelosn.
Acceso Abierto
Atribución-NoComercial-SinDerivadas
10.1101/2020.04.02.20047050
We report the change in the QT interval in 84 adult patients with SARS-CoV-2 infection treated with Hydroxychloroquine/Azithromycin combination. QTc prolonged maximally from baseline between days 3 and 4. in 30% of patients QTc increased by greater than 40ms. In 11% of patients QTc increased to >500 ms, representing high risk group for arrhythmia. The development of acute renal failure but not baseline QTc was a strong predictor of extreme QTc prolongation.
www.medrxiv.org
2020
Artículo
https://www.medrxiv.org/content/10.1101/2020.04.02.20047050v1.full.pdf
Inglés
VIRUS RESPIRATORIOS
Aparece en las colecciones: Artículos científicos

Cargar archivos:


Fichero Tamaño Formato  
1101629.pdf190.07 kBAdobe PDFVisualizar/Abrir